Company news
Monopar Therapeutics Inc. news in 2023
Monopar Therapeutics Inc.'s news releases, calls and decks from 2023, newest first.
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
November 8, 2023
Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
October 31, 2023
Monopar to Participate in the Roth MKM 2023 Healthcare Opportunities Conference
October 9, 2023
Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 4, 2023
Monopar Therapeutics Reports Second Quarter 2023 Financial Results and Recent Developments
August 9, 2023
Monopar Provides Encouraging Camsirubicin Clinical Data Update
August 7, 2023
Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore
July 10, 2023
Monopar to Participate in the Radiopharma Forum by the Lake 2023
June 20, 2023
Monopar to Participate in the Maxim Group’s Healthcare Virtual Conference
June 13, 2023
Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update
May 31, 2023
Monopar Therapeutics Reports First Quarter 2023 Financial Results and Recent Developments
May 10, 2023
Monopar to Present at the Jefferies Radiopharma Innovation Summit
March 27, 2023
Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis
March 26, 2023
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Developments
March 22, 2023
Monopar to Present at the 35th Annual Roth Conference
March 6, 2023
Monopar and NorthStar Announce Expanded Radiopharma Program, Positive Preclinical Results, and Visibility Toward Human Trials
February 26, 2023
Monopar Announces Camsirubicin Clinical Program Update - Improved Side Effect Profile Seen to Date Compared to Doxorubicin
February 13, 2023
Monopar Announces Projected Timeline of Upcoming Q1 2023 Data Events for Validive, Camsirubicin, and MNPR-101 RIT
January 25, 2023
Monopar Announces Successful Advancement of Camsirubicin Phase 1b Clinical Trial Past Fourth Cohort, Escalates Next to 650mg/m2
January 17, 2023